Robyn Bruen

400 total citations
10 papers, 321 citations indexed

About

Robyn Bruen is a scholar working on Immunology, Surgery and Molecular Biology. According to data from OpenAlex, Robyn Bruen has authored 10 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Robyn Bruen's work include Cholesterol and Lipid Metabolism (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Robyn Bruen is often cited by papers focused on Cholesterol and Lipid Metabolism (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Robyn Bruen collaborates with scholars based in Ireland and United Kingdom. Robyn Bruen's co-authors include Orina Belton, Stephen Fitzsimons, Fiona C. McGillicuddy, M. O'Reilly, Eugène Dillon, Eoin Brennan, Daniel Crean, Catherine Godson, Mary Barry and Margaret B. Lucitt and has published in prestigious journals such as The FASEB Journal, Journal of Pharmacology and Experimental Therapeutics and Frontiers in Immunology.

In The Last Decade

Robyn Bruen

10 papers receiving 317 citations

Peers

Robyn Bruen

MB

EDM

CR

IMMUN

SURGE

Guofei Ren China

Chatri Settasatian Thailand

Abdullatif Taha Babakr Saudi Arabia

Hailong Ou China

Ajeeth K. Pingili United States

Alexis Stamatikos United States

Haibing Yu China

Shanshan Lin China

Liufeng Mao China

Guofei Ren China

Robyn Bruen

171 ×1.1

MB

74 ×0.8

EDM

37 ×0.5

CR

35 ×0.6

IMMUN

44 ×0.9

SURGE

Citations per year, relative to Robyn Bruen Robyn Bruen (= 1×) peers Guofei Ren

Countries citing papers authored by Robyn Bruen

Since Specialization

Citations

This map shows the geographic impact of Robyn Bruen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robyn Bruen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robyn Bruen more than expected).

Fields of papers citing papers by Robyn Bruen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robyn Bruen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robyn Bruen. The network helps show where Robyn Bruen may publish in the future.

Co-authorship network of co-authors of Robyn Bruen

This figure shows the co-authorship network connecting the top 25 collaborators of Robyn Bruen. A scholar is included among the top collaborators of Robyn Bruen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robyn Bruen. Robyn Bruen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Fitzsimons, Stephen, Silvia Oggero, Robyn Bruen, et al.. (2020). microRNA-155 Is Decreased During Atherosclerosis Regression and Is Increased in Urinary Extracellular Vesicles During Atherosclerosis Progression. Frontiers in Immunology. 11. 576516–576516. 39 indexed citations

2.

O'Reilly, M., Eugène Dillon, Robyn Bruen, et al.. (2020). Conjugated Linoleic Acid and Alpha Linolenic Acid Improve Cholesterol Homeostasis in Obesity by Modulating Distinct Hepatic Protein Pathways. Molecular Nutrition & Food Research. 64(7). e1900599–e1900599. 31 indexed citations

3.

Bruen, Robyn, M. O'Reilly, Eugène Dillon, et al.. (2019). Liraglutide Attenuates Preestablished Atherosclerosis in Apolipoprotein E–Deficient Mice via Regulation of Immune Cell Phenotypes and Proinflammatory Mediators. Journal of Pharmacology and Experimental Therapeutics. 370(3). 447–458. 43 indexed citations

4.

Bruen, Robyn, Stephen Fitzsimons, & Orina Belton. (2019). miR-155 in the Resolution of Atherosclerosis. Frontiers in Pharmacology. 10. 463–463. 65 indexed citations

5.

Bruen, Robyn, M. O'Reilly, Eugène Dillon, et al.. (2019). Different monocyte phenotypes result in proresolving macrophages in conjugated linoleic acid‐induced attenuated progression and regression of atherosclerosis. The FASEB Journal. 33(10). 11006–11020. 9 indexed citations

6.

Fitzsimons, Stephen, et al.. (2019). Microrna-155 And Conjugated Linoleic Acid In The Context Of Atherosclerosis. Atherosclerosis. 287. e24–e24. 1 indexed citations

7.

Melo, Ashanty M., Lei Zhang, Andreea Petrasca, et al.. (2018). Novel thioglycoside analogs of α-galactosylceramide stimulate cytotoxicity and preferential Th1 cytokine production by human invariant natural killer T cells. Glycobiology. 28(7). 512–521. 13 indexed citations

8.

Bruen, Robyn, Daniel Crean, M. O'Reilly, et al.. (2017). Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis. Cardiovascular Diabetology. 16(1). 143–143. 66 indexed citations

9.

O'Reilly, M., et al.. (2017). To investigate the effect of ALA and CLA on glucose tolerance and adipose tissue inflammation in the ApoE.3L.CETP transgenic mouse model. Proceedings of The Nutrition Society. 76(OCE3). 1 indexed citations

10.

Bruen, Robyn, Stephen Fitzsimons, & Orina Belton. (2016). Atheroprotective effects of conjugated linoleic acid. British Journal of Clinical Pharmacology. 83(1). 46–53. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact